Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. The company's products include LEGIO X COVID-19, a COVID-19 rapid antigen test; and LEGIO X In…
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
Results 2026-05-02
Interim MD&A - English.pdf
Results 2026-05-02
Interim financial statements/report – English.pdf
News 2026-02-17
Other.pdf
Results 2025-12-30 Financials
Interim MD&A - English.pdf
Results 2025-12-30 Financials
Interim financial statements/report – English.pdf
Transactions 2025-12-30 Financing
Gemina Laboratories Announces Debenture Offering and Intention to Voluntarily Delist from CSE
News release - English.pdf
News 2025-11-07
News release - English.pdf
News 2025-10-08
Material change report - English.pdf
News 2025-10-01
News release - English.pdf
Results 2025-10-01 Financials
Interim MD&A - English.pdf
Results 2025-10-01 Financials
Interim financial statements/report – English.pdf
News 2025-08-12
Statement of executive compensation (form 51-102F6V) - English.pdf
Results 2025-06-27 Financials
Interim MD&A - English.pdf
Results 2025-06-27 Financials
Interim financial statements/report – English.pdf